GSE99875
786-0 renal cell carcinoma cell line Everolimus treatment
We present transcriptome profiling of 786-0 renal cell carcinoma cell lines both with and without Everolimus, an mTOR inhibitorhbn Overall design: 786-0 cells were treated with either a control DMSO vehicle or 10um Everolimus, an mTOR inhibitor, for 4 hours